- Home
- TVRD vs TCMD Comparison
TVRD vs TCMD Comparison
Compare TVRD & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- TCMD
- Stock Information
- Founded
- TVRD 2017
- TCMD 1995
- Country
- TVRD United States
- TCMD United States
- Employees
- TVRD N/A
- TCMD N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- TVRD Health Care
- TCMD Health Care
- Exchange
- TVRD Nasdaq
- TCMD Nasdaq
- Market Cap
- TVRD 246.5M
- TCMD 235.5M
- IPO Year
- TVRD N/A
- TCMD 2016
- Fundamental
- Price
- TVRD $24.14
- TCMD $12.18
- Analyst Decision
- TVRD Strong Buy
- TCMD Hold
- Analyst Count
- TVRD 5
- TCMD 3
- Target Price
- TVRD $59.20
- TCMD $13.50
- AVG Volume (30 Days)
- TVRD 38.6K
- TCMD 232.9K
- Earning Date
- TVRD 08-21-2025
- TCMD 08-04-2025
- Dividend Yield
- TVRD N/A
- TCMD N/A
- EPS Growth
- TVRD N/A
- TCMD N/A
- EPS
- TVRD N/A
- TCMD 0.63
- Revenue
- TVRD N/A
- TCMD $298,851,000.00
- Revenue This Year
- TVRD N/A
- TCMD $7.96
- Revenue Next Year
- TVRD N/A
- TCMD $8.53
- P/E Ratio
- TVRD N/A
- TCMD $19.21
- Revenue Growth
- TVRD N/A
- TCMD 6.15
- 52 Week Low
- TVRD $8.13
- TCMD $8.61
- 52 Week High
- TVRD $34.31
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- TCMD 72.40
- Support Level
- TVRD N/A
- TCMD $10.09
- Resistance Level
- TVRD N/A
- TCMD $10.76
- Average True Range (ATR)
- TVRD 0.00
- TCMD 0.57
- MACD
- TVRD 0.00
- TCMD 0.15
- Stochastic Oscillator
- TVRD 0.00
- TCMD 70.86
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.